Bonree(688229)2025-04-25 10:55Financial Performance - The company's revenue for Q1 2025 was CNY 36,210,318.28, a decrease of 3.81% compared to CNY 37,645,165.47 in the same period last year[2] - The net loss attributable to shareholders was CNY -9,205,137.92, an improvement from CNY -13,997,306.02 year-over-year[2] - Basic earnings per share for the period was CNY -0.21, compared to CNY -0.32 in the previous year[3] - The net profit for the first quarter of 2025 was -9,276,596.50 RMB, compared to -13,997,306.02 RMB in the same period of 2024, indicating an improvement of approximately 33.5% year-over-year[17] - The total comprehensive income for Q1 2025 was -9,276,596.50 RMB, compared to -13,997,306.02 RMB in Q1 2024, indicating a year-over-year improvement of about 33.5%[18] Expenses and Costs - Research and development expenses totaled CNY 15,991,979.28, representing 44.16% of revenue, down from 49.44% in the previous year[3] - Total operating costs for Q1 2025 were RMB 46,213,325.32, down 11.54% from RMB 52,261,965.58 in Q1 2024[16] - Research and development expenses in Q1 2025 amounted to RMB 15,991,979.28, a decrease of 14.06% compared to RMB 18,613,283.83 in Q1 2024[16] - The company is focusing on cost reduction and efficiency improvement, leading to a decrease in sales, management, and R&D expenses by CNY 429.93 million, CNY 392.80 million, and CNY 262.13 million respectively[6] Cash Flow and Liquidity - The net cash flow from operating activities was CNY -27,670,694.47, an improvement from CNY -33,619,901.96 in the previous year[2] - Operating cash flow for the first quarter of 2025 was -27,670,694.47 RMB, an improvement from -33,619,901.96 RMB in the first quarter of 2024[20] - The total cash and cash equivalents at the end of Q1 2025 were 302,259,089.47 RMB, down from 378,137,861.55 RMB at the end of Q1 2024[21] - Cash and cash equivalents as of March 31, 2025, were RMB 303,270,064.39, down from RMB 331,850,210.41 as of December 31, 2024[10] - The cash flow from investing activities in Q1 2025 was 181,248.44 RMB, down from 449,195.34 RMB in Q1 2024, indicating a decrease of about 59.6%[20] Assets and Liabilities - The total assets at the end of the reporting period were CNY 476,266,782.25, a decrease of 1.83% from CNY 485,154,250.31 at the end of the previous year[3] - Total assets as of March 31, 2025, were RMB 476,266,782.25, a decrease from RMB 485,154,250.31 as of December 31, 2024[12] - Total liabilities as of March 31, 2025, were RMB 65,468,123.93, slightly up from RMB 65,079,006.67 as of December 31, 2024[12] - The company's equity attributable to shareholders was RMB 410,896,783.23 as of March 31, 2025, down from RMB 420,101,909.97 as of December 31, 2024[13] Shareholder Information - The top three shareholders hold a combined 45.13% of the shares, with the largest shareholder owning 23.12%[7] Other Income and Gains - The company reported non-recurring gains of CNY 338,714.85, primarily from government subsidies and other non-operating income[5] - The company reported a significant increase in other income, which rose to 1,619,920.73 RMB in Q1 2025 from 508,465.44 RMB in Q1 2024[17] Investment and Interest - The company incurred interest expenses of 52,797.93 RMB in Q1 2025, compared to 55,604.15 RMB in Q1 2024, showing a decrease of approximately 5%[17] - The company’s investment income showed a loss of -79,605.63 RMB in Q1 2025, a decline from a gain of 511,691.84 RMB in Q1 2024[17] Market and Product Development - The company has not reported any significant new product developments or market expansions during this period[9]